Form D Explorer

Form D — Crosslink Therapeutics Inc.

0002067583-26-000002 · filed Oct 20, 2026

Offering

Industry: Pharmaceuticals
Exemptions: 06b
Total offering: $5,500,000
Total sold: $5,500,000
Minimum investment: $0
Investors: —
Sales commission: —
Finders' fees: —

Issuer

Name: Crosslink Therapeutics Inc.
CIK: 2067583
Entity: Corporation
Jurisdiction: DELAWARE
Year incorporated: 2021
Address: 349-351 NEWBURY STREET
BOSTON, MA 02115
Phone: 404-861-1253

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Ronald D. Seidel, III · Executive Officer

Boston, MA Find on LinkedIn ↗
Andrew King · Director

Boston, MA Find on LinkedIn ↗
Lou Tartaglia · Director

Boston, MA Find on LinkedIn ↗
Rodolfo Chaparro · Director

Boston, MA Find on LinkedIn ↗
David Fallace · Director

Boston, MA Find on LinkedIn ↗
Cameron Gallagher · Director

Boston, MA Find on LinkedIn ↗

View the original filing on SEC EDGAR ↗